Global Peptide Therapeutics Market
Pharmaceuticals

Top Trends Driving Innovation and Change in the Peptide Therapeutics Market: Evonik Breakthrough Cqrex Kc Redefines Cell Culture Processes In The Peptide Therapeutics Market

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Peptide Therapeutics Market From 2025 To 2029?

The market size for peptide therapeutics has expanded vigorously in the past few years. It is expected to escalate from $45.15 billion in 2024 to $49.21 billion in 2025, progressing at a compound annual growth rate (CAGR) of 9.0%. Several factors have contributed to the growth in the historic period, including the rising frequency of chronic illnesses, a better understanding of molecular biology, and the growing applications in the field of oncology.

The market size for peptide therapeutics is poised for a significant expansion in the coming years, predicted to reach a value of $74.98 billion by 2029, with a compound annual growth rate (CAGR) of 11.1%. This projected growth over the forecast period is primarily due to an increase in demand for individualized medication, an expanded application in immunotherapy, improvements in peptide delivery systems, new peptide targets for infectious diseases, and an enhanced focus on rare ailments. Key trends for this period include technological development in peptide synthesis, mounting investment and financial backing, a concentration on the safety of peptide drugs, market growth in developing economies, and the incorporation of artificial intelligence (AI).

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

What External and Internal Drivers Are Contributing to the Growth of thePeptide Therapeutics Market?

The peptide therapeutics market is anticipated to witness growth due to the rising prevalence of chronic diseases. These are enduring illnesses that aren’t always curable but can often be managed and treated. The escalating number of chronic diseases can be attributed to factors such as increased tobacco consumption, inadequate nutrition, lack of physical activity, and excessive drinking among others. The utilization of peptide therapeutics is instrumental in combating and treating some of these chronic diseases. For example, a study by the National Library of Medicine, a US institution, in January 2023 suggested that by 2050, the population in the US aged 50 and over, suffering from at least one chronic condition, would surge by 99.5%, resulting in 142.66 million people. Hence, the burgeoning rate of chronic diseases is projected to boost the peptide therapeutics market in the upcoming years.

What Segment Types Define the Peptide Therapeutics Market Structure?

The peptide therapeutics market covered in this report is segmented –

1) By Type: Generic, Branded

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Subsegments:

1) By Generic: Generic Peptide Drugs, Biosimilars

2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Peptide Therapeutics Market?

North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Peptide Therapeutics Market?

Prominent businesses in the peptide therapeutics market are concentrating on creating cutting-edge solutions, including cell culture processes, to secure a market advantage. The cell culture process involves the cultivation of cells outside of their natural environment under controlled conditions. This requires the isolation of specific cells from living tissue and their subsequent preservation. An example of this occurred in June 2023 when Evonik Industries AG, a specialty chemicals company based in Germany, introduced cQrex KC. This next-generation peptide for biopharma applications, designed specifically for the cell culture process, facilitates the manufacturing of biological drugs. The cQrex KC enables those developing cell culture processes to perfect the supply of cystine and boost productivity. Additionally, it aids in the development of vaccines, viral vectors, and cell therapies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

What Is the Definition of the Peptide Therapeutics Market?

Peptide therapeutics refer to a therapeutic approach that uses peptides as medications. Peptides are a distinct family of pharmacological substances that are molecularly situated in between proteins and tiny molecules. Peptides that are found in nature serve a variety of purposes, including those of hormones, growth factors, neurotransmitters, ion channel ligands, and anti-infectives. Consequently, using peptides as treatments offers a way to target a variety of cells and control their response.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7216

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model